To determine whether LOX and HIF-1α expression increases in ovarian cancer tissues, we examined the expression of LOX and HIF-1α in 44 cases of human epithelial ovarian carcinoma, 20 cases of borderline ovarian tumor, 27 cases of benign ovarian tumor and 28 cases of normal ovarian tissues. Here, LOX is linked to ovarian benign neoplasm.